Niki BioSolutions, Inc. Impairment of Long-Lived Assets Held-for-use
Niki BioSolutions, Inc. (NIKI) reported Impairment of Long-Lived Assets Held-for-use of $1.00 million for the 12-month period ending 2024-12-31, per its 6-K filed 2025-10-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-01-22
- Niki BioSolutions, Inc. impairment of long-lived assets held-for-use for the quarter ending 2024-12-31 was -$421.78K.
- Niki BioSolutions, Inc. impairment of long-lived assets held-for-use for the quarter ending 2024-09-30 was -$277.70K.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$421.78K derived: 6-K 12 month − 6-K 9 month · filed 2025-10-08 | -$699.48K derived: sum of 2 quarters · filed 2026-01-22 | $1.00M 6-K · filed 2025-10-08 | |
| 2024-09-30 | -$277.70K derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $1.42M 6-K · filed 2026-01-22 | ||
| 2024-06-30 | $1.70M 6-K · filed 2024-12-20 | |||
| 2023-12-31 | $77.20K 6-K · filed 2025-10-08 | |||
| 2023-06-30 | $750.38K 6-K · filed 2024-12-20 | |||
| 2022-12-31 | $520.82K 6-K · filed 2025-10-08 |